Completed PHASE2 INTERVENTIONAL 2-arm NCT01132781

Theophylline in Rhinitis

The Effect of Theophylline in Patients With Allergic Rhinitis

Sponsor: Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

Conditions Allergic Rhinitis Asthma Rhinosinusitis

Interventions Placebo (Placebo Group) Theophylline (Intervention Group)

Updated 6 times since 2017 Last updated: Aug 22, 2012 Started: May 31, 2010 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01132781, this PHASE2 trial focuses on Allergic Rhinitis and Asthma and remains completed. Sponsored by Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK), it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
University of East Anglia

Data source: University of East Anglia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Norwich, United Kingdom